{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Brentwood",
      "state": "TN",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "87186",
      "recalling_firm": "Cairn Diagnostics",
      "address_1": "105 Westpark Dr Ste 150",
      "address_2": "N/A",
      "postal_code": "37027-1012",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "US Nationwide distribution in the states of GA, NY, MI, CA, KS, NC.",
      "recall_number": "Z-1128-2021",
      "product_description": "13C-Spirulina Gastric Emptying Breath Test (GEBT) - Product Usage: intended for use in the measurement of the rate of gastric emptying of solids and as an aid in the diagnosis of delayed gastric emptying (gastroparesis) in adult humans who are symptomatic for gastroparesis.",
      "product_quantity": "103 kits",
      "reason_for_recall": "Potential for false negative diagnosis of gastroparesis.  Certain GEBT kits containing 13C-Spirulina elicit unusually high 13CO2-excretion rates",
      "recall_initiation_date": "20210108",
      "center_classification_date": "20210216",
      "termination_date": "20230809",
      "report_date": "20210224",
      "code_info": "Lot Codes:  K021-021R, K021-022"
    }
  ]
}